Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer

Summary: The clinical utility of circulating tumor DNA (ctDNA) in hormone-sensitive prostate cancer (HSPC) remains inadequately elucidated. This study presents the largest real-world cohort to conduct a concordance analysis between ctDNA and tissue-based genomic profiling in HSPC patients. The findi...

Full description

Bibliographic Details
Main Authors: Bin Yang, Tingting Zhao, Baijun Dong, Wei Chen, Guanjie Yang, Jun Xie, Changcheng Guo, Ruiliang Wang, Hong Wang, Longfei Huang, Bo Peng, Wei Xue, Xudong Yao
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224001524